Phylogica Limited

ASX:PYC ISIN:AU000000PYC7

Phylogica Limited (Phylogica) is an Australia-based company principally engaged in the discovery and development of therapeutics directed at proteins and their interactions. The Company is engaged in the discovery of peptide-based drugs to treat inflammatory diseases.  
 
        

Lihat di Bahasa Lain

Berita

Laporan Pasar Australia 20 Desember 2010: IMX Resources (ASX:IXR) Meluncurkan Pengapalan Pertama Biji Tembaga Besinya ke Cina

🕔12/20/2010 1:30:00 PM 13187

Laporan Pasar Australia 20 Desember 2010 memuat: IMX Resources Limited (ASX:IXR) telah meluncurkan pengapalan pertamanya untuk biji tembaga besi ke Cina; Phylogica Limited (ASX:PYC) menanda tangani perjanjian kolaborasi danlisensi dengan Pfizer (NYSE:PFE); Copper Strike Limited (ASX:CSE) menerima hasil yang kuat untuk tembaga, perak, kobalt di Walford Creek, Queensland Baratlaut; Produksi biji besi South American Ferro Metals Limited (ASX:SFZ) di Brazil melampaui 400.000 ton.

Baca Full Story▸
###

86,414 TAMPILAN PROFIL PERUSAHAAN

  • Halaman ini dilihat: (7 Hari Terakhir: 27) (30 Hari Terakhir: 92) (Sejak Ditampilkan: 9040) 

Data Perusahaan

    Fax
  • 08 9423 8899 
    • Sektor Utama
  • Kesehatan & Pharm 
    • Industri Utama
  • Biotechnology 
    • Homepage
  • www.phylogica.com/

Lebih banyak Berita lagi

  • 2024/11/22: Presentation of RP11 Clinical Trial Data at APVRS 2024*
  • 2024/11/21: Completion of Share Consolidation*
  • 2024/11/14: Share Consolidation and ASX Code*
  • 2024/11/13: Update - Consolidation/Split - PYC*
  • 2024/11/13: Results of Annual General Meeting*
  • 2024/11/13: 2024 AGM Chairman's Address and CEO Presentation*
  • 2024/11/11: Consolidation/Split - PYC*
  • 2024/11/06: Annual General Meeting - Conference Call Details*
  • 2024/11/05: RP11 SRC Approves Dose Escalation to Final Patient Cohort*
  • 2024/11/01: First ADOA Patient Dosed in Clinical Trial*
*refer to company website